Alerts will be sent to your verified email
Verify Email
VIMTALABS
|
Vimta Labs
|
Krsnaa Diagnostics
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.71 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
12.51 % | 8.47 % | 21.92 % |
|
5yr average Equity Multiplier
|
1.33 | 1.32 | 1.35 |
|
5yr Average Asset Turnover Ratio
|
0.82 | 0.53 | 0.83 |
|
5yr Avg Net Profit Margin
|
11.37 % | 12.31 % | 19.57 % |
|
Price to Book
|
6.8 | 2.97 | 7.45 |
|
P/E
|
37.98 | 32.96 | 46.44 |
|
5yr Avg Cash Conversion Cycle
|
122.88 Days | -95.52 Days | -5.15 Days |
|
Inventory Days
|
26.64 Days | 12.7 Days | 17.88 Days |
|
Days Receivable
|
95.75 Days | 73.45 Days | 41.03 Days |
|
Days Payable
|
315.03 Days | 332.62 Days | 51.63 Days |
|
5yr Average Interest Coverage Ratio
|
21.55 | 7.45 | 72.56 |
|
5yr Avg ROCE
|
16.46 % | 11.5 % | 28.32 % |
|
5yr Avg Operating Profit Margin
|
25.53 % | 25.75 % | 32.43 % |
|
5 yr average Debt to Equity
|
0.11 | 0.1 | 0.01 |
|
5yr CAGR Net Profit
|
43.08 % | -3.63 % | -4.3 % |
|
5yr Average Return on Assets
|
9.62 % | 6.5 % | 16.06 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
36.7 % | 27.24 % | 71.06 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 100.0 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.76 % | -0.14 % | -0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.48 % | -1.2 % | 8.41 % |
|
Vimta Labs
|
Krsnaa Diagnostics
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|